Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Andy Stoll: Entrepreneurial ecosystem answers aren’t inside the Kauffman Foundation
Editor’s note: This content was sponsored by the Ewing Marion Kauffman Foundation but independently produced by Startland News. Acting in a Bollywood film. Pie making on Armenian television. Cooking on a dude ranch in Australia. Sewing in a dress factory in Bangkok. Farming maize in Zambia. Each revealed a lesson and mission for Andy Stoll.…
Rx Savings secures $18.4M funding round, nears 2 million members
An $18.4 million funding round is the prescription Rx Savings Solutions needs to expand its fight against a crippling, yet common ailment, said Michael Rea. “Everyone in the nation has the same problem — high drug costs — and most people don’t know there are options to save money,” said Rea, founder and chief executive…
Before prime time: Did Amazon’s 1999 arrival in Kansas deliver on hype?
In 1999, Amazon — still in its infancy — meant only two things to most consumers: low-priced books and CDs. But for one small town in Kansas, residents believed the online retailer had the potential to be a game-changer for their economically depressed, rural community. “People in Coffeyville were practically doing cartwheels in the streets,” said…
FCC head: Repealing net neutrality will boost innovation, investment; startups disagree
The Federal Communications Commission is preparing to eliminate regulatory rules that prohibit internet service providers from interfering with consumers’ access to web content. FCC chairman Ajit Pai announced in a Wall Street Journal op-ed that the regulatory body will vote Dec. 14 to repeal 2015 Obama-era regulations. That regulatory model, referred to as Title II,…